T2D-Bench: Evidence-Gated Evaluation of LLM Outputs for Type 2 Diabetes Using a Multi-Layer Clinical-Lifestyle Knowledge Graph
arXiv AIArchived Jun 24, 2026✓ Full text saved
arXiv:2606.24145v1 Announce Type: new Abstract: Large language models (LLMs) can produce clinically fluent recommendations for type 2 diabetes while failing to satisfy guideline constraints or explicitly justify lifestyle-related glycemic claims. We present T2D-Bench, a reproducible benchmark and evidence-gated evaluation framework for testing whether LLM outputs satisfy explicit, graph-checkable evidence requirements. T2D-Bench is built on a multi-layer clinical-lifestyle knowledge graph that c
Full text archived locally
✦ AI Summary· Claude Sonnet
Computer Science > Artificial Intelligence
[Submitted on 23 Jun 2026]
T2D-Bench: Evidence-Gated Evaluation of LLM Outputs for Type 2 Diabetes Using a Multi-Layer Clinical-Lifestyle Knowledge Graph
Saba A. Farahani, Hung Cao, Ramesh Jain, Amir M. Rahmani
Large language models (LLMs) can produce clinically fluent recommendations for type 2 diabetes while failing to satisfy guideline constraints or explicitly justify lifestyle-related glycemic claims. We present T2D-Bench, a reproducible benchmark and evidence-gated evaluation framework for testing whether LLM outputs satisfy explicit, graph-checkable evidence requirements. T2D-Bench is built on a multi-layer clinical-lifestyle knowledge graph that combines a biomedical spine (UMLS, DrugBank, SIDER), computable ADA Standards of Care rules, and lifestyle knowledge connected through a mechanistic bridge to glycemic laboratory effects. Across 100 structured vignettes spanning diagnosis, medication safety, and adversarial lifestyle conflicts, baseline outputs failed benchmark-defined evidence-path checks in 35% of cases for GPT-4o-mini and 33% for GPT-4o. The evidence gate detects unsupported omissions and uses constrained revision to bring outputs into verifier-level compliance with benchmark-defined evidence requirements. These results show that computable evidence constraints can make unsupported clinical omissions explicit, measurable, and correctable in diabetes-focused LLM outputs.
Comments: 7 pages, 2 figures, 2 tables. Accepted as a poster at AMIA 2026 Annual Symposium
Subjects: Artificial Intelligence (cs.AI)
Cite as: arXiv:2606.24145 [cs.AI]
(or arXiv:2606.24145v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2606.24145
Focus to learn more
Submission history
From: Saba Azizabadi Farahani [view email]
[v1] Tue, 23 Jun 2026 05:02:21 UTC (549 KB)
Access Paper:
view license
Current browse context:
cs.AI
< prev | next >
new | recent | 2026-06
Change to browse by:
cs
References & Citations
NASA ADS
Google Scholar
Semantic Scholar
Export BibTeX Citation
Bookmark
Bibliographic Tools
Bibliographic and Citation Tools
Bibliographic Explorer Toggle
Bibliographic Explorer (What is the Explorer?)
Connected Papers Toggle
Connected Papers (What is Connected Papers?)
Litmaps Toggle
Litmaps (What is Litmaps?)
scite.ai Toggle
scite Smart Citations (What are Smart Citations?)
Code, Data, Media
Demos
Related Papers
About arXivLabs
Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)